NewLink gains fast-track support for Ebola vaccine
BPC Staff Jul 27, 2016 | 3:49 pm
<1 min read time
22 wordsAll Latest News, Health and Wellness, Statewide NewsAmes Tribune: Ames-based biopharmaceutical company NewLink Genetics has secured fast-track priority from U.S. and European drug regulators for a potential Ebola vaccine.